Opko Health Inc. | Small-cap | Healthcare
$1.34
-1.47%
| Opko Health Stock Comparison:
Opko Health vs Thermo FisherOpko Health vs DanaherOpko Health vs Twist BioscienceOpko Health vs GrailOpko Health vs NeogenOpko Health vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 713.1M
Gross Profit 218.5M 30.64%
Operating Income -273.6M -38.36%
Net Income -53.2M -7.46%
EPS (Diluted) -$0.08

Balance Sheet Metrics

Total Assets 2.2B
Total Liabilities 834.8M
Shareholders Equity 1.4B
Debt to Equity 0.61

Cash Flow Metrics

Operating Cash Flow 67.1M
Free Cash Flow -208.5M

Revenue & Profitability Trend

Opko Health Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue713.1M863.5M1.0B1.8B1.4B
Cost of Goods Sold494.6M545.4M716.0M1.2B894.4M
Gross Profit218.5M318.1M288.2M581.5M541.0M
Operating Expenses409.4M390.2M446.6M545.7M430.9M
Operating Income-273.6M-158.1M-246.1M-14.5M53.7M
Pre-tax Income-10.4M-184.3M-391.5M-14.0M48.7M
Income Tax42.8M4.4M-63.5M15.5M17.6M
Net Income-53.2M-188.9M-328.4M-30.1M30.6M
EPS (Diluted)-$0.08-$0.25-$0.46-$0.05$0.05

Income Statement Trend

Opko Health Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets662.1M309.5M394.5M823.0M523.2M
Non-Current Assets1.5B1.7B1.8B1.6B1.9B
Total Assets2.2B2.0B2.2B2.4B2.5B
Liabilities
Current Liabilities193.1M200.1M213.5M330.0M375.5M
Non-Current Liabilities641.7M422.4M392.1M384.6M426.0M
Total Liabilities834.8M622.5M605.6M714.6M801.5M
Equity
Total Shareholders Equity1.4B1.4B1.6B1.7B1.7B

Balance Sheet Composition

Opko Health Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-53.2M-188.9M-328.4M-30.1M30.6M
Operating Cash Flow67.1M-41.9M-139.6M101.4M-32.0M
Investing Activities
Capital Expenditures242.0K2.7M2.0M66.0M245.0K
Investing Cash Flow377.2M-1.9M115.6M68.1M15.4M
Financing Activities
Dividends Paid-----
Financing Cash Flow184.4M-11.0M23.7M-22.7M-71.7M
Free Cash Flow-208.5M-44.5M-119.8M6.2M5.8M

Cash Flow Trend

Opko Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -16.12
Forward P/E -4.38
Price to Book 0.65
Price to Sales 1.46
PEG Ratio -4.38

Profitability Ratios

Profit Margin -5.66%
Operating Margin -44.79%
Return on Equity -3.04%
Return on Assets -8.20%

Financial Health

Current Ratio 2.49
Debt to Equity 37.58
Beta 1.37

Per Share Data

EPS (TTM) -$0.06
Book Value per Share $1.95
Revenue per Share $1.01

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
opk1.0B-16.120.65-3.04%-5.66%37.58
Thermo Fisher 152.5B23.693.0913.70%15.19%69.23
Danaher 140.5B37.982.767.22%15.81%34.56
Twist Bioscience 2.2B-9.854.89-38.22%-54.98%18.25
Grail 1.5B-0.700.61-62.22%-62.12%2.67
Neogen 1.0B865.000.39-16.71%-53.56%33.61

Financial data is updated regularly. All figures are in the company's reporting currency.